XRC Ventures

Come work with us! We're #hiring for the below positions! - Partner, XRC Pre-Seed Accelerator Fund (NYC) - Principal, Pre-Seed Accelerator Fund (NYC) - Director, Marketing & Communications (NYC) - Intern, Fund Management (Remote) - Interns, Sourcing and Investment (Remote) Please apply through our careers page here: https://lnkd.in/eY9AfxzH

Announcing Steve Madden x HILOS at TechCrunch Disrupt The American fashion icon is teaming up with HILOS for an on-demand future https://lnkd.in/gEgjh94H

We've been named to Inc. Magazine's 2024 Founder-Friendly Investors list ?? This award reflects our commitment to supporting visionary entrepreneurs and groundbreaking ventures at the intersection of consumer behavior and technology. Thanks to our portfolio companies, partners, and dedicated team members whose innovative thinking and hard work made this possible. Check out the full list at bit.ly/40j6hN9.

The failure of the consumerization of healthcare is not a function of what the consumer wants, it's the inability of enterprise to deliver what they're asking for. During HLTH USA a few days ago, Peter Birch spoke with Pano Anthos from XRC Ventures about: ?? Why have retailers moved away from store-based healthcare ?? New care delivery models that will change the game of healthcare ?? The evolution of wearables and their impact on health monitoring ?? Current trends in consumer health that will make it more accessible and affordable Subscribe to the Talking HealthTech newsletter to find out when you can catch the full conversation, along with over 20 other important conversations we had during the event. ???? https://lnkd.in/grfBJSH #healthtech #hlthusa #hlth2024 HLTH Inc.Health Podcast Network

Congrats to Croissant for inclusion in The Information's 50 Most Promising Startups list. ??

Have you read our new Consumer VC Benchmarks report on #womenshealth? Download it at bit.ly/3BMYhd4. Key Insights: - Women make 80% of household healthcare decisions and control 70-80% of discretionary spending, but only ~1% of healthcare research and innovation is invested in female-specific conditions beyond oncology. - We see strong potential in hormonal health, particularly menopause. 85% of women experience menopause symptoms. Although 60% of women seek clinical help, a staggering 75% of them remain untreated. - 90% of surveyed investors plan to maintain or increase their investments in Women’s Health startups for 2024. For those attending HLTH USA, join our Founding Partner Pano Anthos at today's session titled "Consumer Wellness Means Business" to discuss more. #hlth #healthcareonLinkedIn

Congrats Gather AI on this shining customer review by GEODIS. ?? Read more below. ??

For those attending HLTH USA, we invite you to join Pano Anthos tomorrow from 10:40 –?11:20 AM?PDT at the Evergreen Stage for a panel titled "Consumer Wellness Means Business," where panelists will discuss the climate around early-stage investments, consumer priorities and forecasts for years ahead. See you there!

I really enjoyed speaking at the HBS retail and luxury conference today. It is always great to meet with students with such energy and enthusiasm. Lots of room to innovate in this market with such bright students. Dawn Dobras Kathryn Cavanaugh Brendan Hanrahan David Paresky. And thank you Jennifer Anger Daphne Chow . #futureofretail #futureofconsumer #futureoffuture

XRC's latest Consumer VC Benchmarks are in! ?? Our newest report highlights industry trends and investment opportunities in Women's Health. ??♀? Download the free report here: bit.ly/3BMYhd4 Key Insights: - Women make 80% of household healthcare decisions and control 70-80% of discretionary spending, but only ~1% of healthcare research and innovation is invested in female-specific conditions beyond oncology. We believe the disconnect between the demand and supply of Women’s Health innovations presents a compelling investment opportunity. - XRC sees strong potential in hormonal health, particularly menopause. 85% of women experience menopause symptoms. Although 60% of women seek clinical help, a staggering 75% of them remain untreated. We believe this unmet need has driven women to actively seek out solutions, creating a significant market opportunity. - 90% of surveyed investors plan to maintain or increase their investments in Women’s Health startups for 2024. The most important attributes investors look for are: 1) strength of the brand; and 2) clinical studies. Thanks to our participants: Daniel Faierman at Habitat Partners, Odile Roujol at Fab Co-Creation Studio Ventures, Rana Taghdisi Argenio & Nina Faulhaber at Palette Ventures, Kirsty Macdonald at JamJar Investments, Jun Deng PhD at Joyance Partners, Clementine Provost at Unilever Ventures, Maria D. Toler at SteelSky Ventures & Josie Buck at Venrex. And great work, Diana Melencio, Kelly Chen, and John Buccheri for spearheading the development of this report. https://lnkd.in/e7WiGhSX